TU:NYSETelus Corporation Analysis
Data as of 2026-05-06 - not real-time
$12.82
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
TELUS shares are trading at $12.82, just above the 20‑day SMA of 12.32 but still below the 50‑day SMA of 12.87 and the 200‑day SMA of 14.23, indicating a short‑term pullback within a longer‑term downtrend. The RSI sits at 57.8, suggesting neutral momentum, while the MACD histogram is positive and the signal line is bullish, offering a brief technical upside that is capped by a resistance level near 12.89. Volume is decreasing, volatility is high at 27.8% over the past 30 days, and beta is exceptionally low (0.14), meaning market swings have limited impact but company‑specific risk is elevated.
Fundamentally, the stock appears overvalued—the DCF fair value of roughly 4.9 dollars implies a price discount of over 35% relative to the current level. Revenue is contracting (-1.9% YoY) and margins are modest, while debt is massive (debt‑to‑equity ~191) and the dividend payout ratio exceeds 229%, flagging unsustainable dividend practices. With a PE of 24 versus an industry average of 17, the stock leans heavily toward a value profile, and the combination of high leverage, weak growth, and an inflated price suggests investors should be cautious.
Fundamentally, the stock appears overvalued—the DCF fair value of roughly 4.9 dollars implies a price discount of over 35% relative to the current level. Revenue is contracting (-1.9% YoY) and margins are modest, while debt is massive (debt‑to‑equity ~191) and the dividend payout ratio exceeds 229%, flagging unsustainable dividend practices. With a PE of 24 versus an industry average of 17, the stock leans heavily toward a value profile, and the combination of high leverage, weak growth, and an inflated price suggests investors should be cautious.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price near resistance at $12.89 with decreasing volume
- Technical indicators show mixed signals (bullish MACD, neutral RSI)
- High short‑term volatility (~28%)
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Overvaluation relative to DCF fair value
- Unsustainable dividend payout (>200%)
- Elevated debt load (debt‑to‑equity ~191)
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- Persistent revenue decline and low growth prospects
- High leverage limiting financial flexibility
- Valuation gap suggests potential price correction
Key Metrics & Analysis
Financial Health
Revenue Growth-1.90%
Profit Margin5.47%
P/E Ratio24.2
ROE4.66%
ROA3.40%
Debt/Equity190.69
P/B Ratio1.7
Op. Cash Flow$4.9B
Free Cash Flow$2.8B
Industry P/E17.3
Technical Analysis
TrendBearish
RSI57.8
Support$11.69
Resistance$12.89
MA 20$12.32
MA 50$12.87
MA 200$14.23
MACDBullish
VolumeDecreasing
Fear & Greed Index90.34
Valuation
Fair Value$4.90
Target Price$17.33
Upside/Downside35.21%
GradeOvervalued
TypeValue
Dividend Yield9.56%
Risk Assessment
Beta0.14
Volatility27.78%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.